64Cu-DOTA-U3-1287

64Cu-DOTA-U3-1287 · Washington University School of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 64Cu-DOTA-U3-1287, covering 2013-12-20 to 2013-12-20. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid Tumors [Phase 1]